# Associations Between Depression and Reduced Quality of Life in Women with Non-Radiographic Axial Spondyloarthritis: A Cross-Sectional Study

**Authors:** Marija Rogoznica Pavlović, Mislav Radic, Andrej Belančić, Kristina Skroče, Karla Vurić, Tatjana Kehler

PMC · DOI: 10.3390/biomedicines14020389 · Biomedicines · 2026-02-08

## TL;DR

This study finds that women with non-radiographic axial spondyloarthritis experience lower quality of life and higher depression and anxiety linked to disease features and duration.

## Contribution

The study identifies specific associations between spondyloarthritis features and disease variables with mental health outcomes in women with nr-axSpA.

## Key findings

- Disease-related variables correlated positively with depression/anxiety scores and negatively with quality of life scores.
- Patients with a family history of spondyloarthritis had lower mental health scores and higher depression scores.
- Depressive symptoms were significantly associated with both spondyloarthritis features and disease variables.

## Abstract

Background/Objectives: Axial spondyloarthritis (axSpA) is a chronic systemic inflammatory disease that adversely affects both physical and mental health. This cross-sectional study aimed to examine the associations between spondyloarthritis features (SpA-fs) and disease-related variables (DRVs: disease duration, Visual Analogue Scale, Ankylosing Spondylitis Disease Activity Score [ASDAS], Bath Ankylosing Spondylitis Disease/Functional Activity Index), as well as potential correlations with quality of life (QoL) and symptoms of anxiety and depression in women with non-radiographic axSpA (nr-axSpA). Methods: This study included 78 women with nr-axSpA. Data were obtained from medical records and assessed using two validated instruments: the Short Form-36 (SF-36) and the Hospital Anxiety and Depression Scale (HADS). Results: The mean age of the cohort was 39.8 ± 7.8 years, with a mean disease duration of 4.80 ± 5.37 years and a mean ASDAS of 2.09 ± 1.14. DRVs, correlated positively with HADS scores and negatively with SF-36 scores. Patients with family histories of SpA had significantly lower mental-component SF-36 scores and higher HADS-D scores. Lower quality of life was associated with DRVs, particularly disease duration. Significant associations with depressive symptoms were observed for both SpA features and DRVs. Conclusions: In women with nr-axSpA, both SpA-fs and DRVs are associated with reduced QoL and elevate the risk of anxiety and depression, underscoring the need for thorough patient evaluation that encompasses psychological health.

## Linked entities

- **Diseases:** ankylosing spondylitis (MONDO:0005306)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}
- **Diseases:** fibromyalgia (MESH:D005356), psychiatric illness (MESH:D001523), substance abuse (MESH:D019966), AxSpA (MESH:D000089183), spondylitis (MESH:D013166), diabetes mellitus (MESH:D003920), enthesitis (MESH:D001171), reduction (MESH:D015431), psychological impairment (MESH:D000067073), Sacroiliitis (MESH:D058566), Anxiety (MESH:D001007), nr (MESH:D000089202), rheumatic disease (MESH:D012216), arthritis (MESH:D001168), inflammation (MESH:D007249), injury to (MESH:D014947), heel (MESH:C563167), QoL (MESH:D003643), sleep disturbances (MESH:D012893), hypertension (MESH:D006973), bodily pain (MESH:D010146), IBP (MESH:D001416), endometriosis (MESH:D004715), psoriatic arthritis (MESH:D015535), congenital genetic disorders (MESH:D030342), MRI abnormalities (MESH:C564543), psoriasis (MESH:D011565), neurological, malignant, or hematological disorders (MESH:D019337), musculoskeletal problems (MESH:D009140), Depression (MESH:D003866), IBD (MESH:D015212), Uveitis (MESH:D014605), fatigue (MESH:D005221), AS (MESH:D013167)
- **Chemicals:** IL-17i (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937723/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937723/full.md

---
Source: https://tomesphere.com/paper/PMC12937723